FDA label 37de3f25-c152-2898-e063-6294a90a8bdd

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
36854129-6ba0-5df7-e063-6394a90ab498
SPL ID
37de3f25-c152-2898-e063-6294a90a8bdd
Version
2
Effective date
2025-06-18
Source export date
2026-09-28
Source partition
9
Source file
https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/6784607726c827491ceaeab30d843632e0660ee8008c535197be5ed9e1e52201/drug-label-0009-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:04:49

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: Warnings For vaginal use only. Not for oral consumption. Suppository may damage condoms and diaphragms, causing them to fail. Do not use If you have never had a yeast infection diagnosed by a doctor • If you are allergic to any of the ingredients. When using this product, do not use tampons, douches, spermicides, or other vaginal products. Ask a doctor before use If you have vaginal itching and discomfort for the first time • If you have lower abdominal, back, or shoulder pain, fever, chills, nausea, vomiting or foul-smelling vaginal discharge • If you have frequent vaginal yeast infections (such as once per month or three in six months) • If you have been exposed to sexually transmitted diseases (STDs). Stop use and ask a doctor If symptoms do not improve within 3 days or last more than 7 days • If you get a rash, hives, abdominal pain, fever, chills, nausea, or vomiting

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.